Every Form 4 that CACI INTERNATIONAL CLA (CACI) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow CACI and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CACI filings page.
CACI International director Philip O. Nolan reported the vesting and conversion of 84 Restricted Stock Units into 84 shares of CACI common stock on January 14, 2026. The Form 4 shows this as a transaction with no exercise price. These RSUs are part of a 338-unit grant awarded on October 17, 2025, which is scheduled to vest in four installments through October 11, 2026. After this vesting event, Nolan directly holds 2,153 shares of CACI common stock and 254 RSUs, reflecting his ongoing equity-based compensation as a director.
CACI International director Charles L. Szews reported the vesting of previously granted equity awards. On January 14, 2026, 84 Restricted Stock Units (RSUs) that were granted on October 17, 2025 vested and were converted into 84 shares of CACI common stock at an exercise price of $0.00 per share.
After this transaction, Szews directly owns 415 shares of CACI common stock and 254 RSUs, which are scheduled to vest later under the original grant of 338 RSUs. The remaining RSUs are expected to vest in three additional installments on April 14, 2026, July 13, 2026, and October 11, 2026.
CACI International director Scott C. Morrison reported the vesting and conversion of restricted stock units into common shares. On January 14, 2026, 84 Restricted Stock Units vested and were converted into 84 shares of CACI common stock at a price of $0.00 per share, reported with transaction code "M". After this transaction, Morrison directly owned 415 shares of CACI common stock and 254 Restricted Stock Units. These RSUs are part of a 338-unit grant made on October 17, 2025 that vests in four installments through October 11, 2026.
CACI International director Susan M. Gordon reported a routine equity compensation vesting. On January 14, 2026, 84 Restricted Stock Units (RSUs) previously granted to her converted into CACI common stock at an exercise price of $0 per share. These RSUs are part of a 338-unit grant awarded on October 17, 2025, scheduled to vest in four installments through October 11, 2026.
Following this transaction, Gordon directly beneficially owned 2,821 shares of CACI common stock and 254 RSUs, reflecting ongoing board compensation rather than an open-market purchase or sale.
CACI International director Stanton D. Sloane reported the vesting of 84 Restricted Stock Units (RSUs) into 84 shares of CACI common stock on January 14, 2026, at an exercise price of $0 per share. After this transaction, he beneficially owned 943 shares of CACI common stock and 254 RSUs directly.
These RSUs are part of a 338-unit grant awarded on October 17, 2025, with a scheduled vesting of 84 shares on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026.
CACI International director Lisa Disbrow reported equity awards tied to her board service. On January 14, 2026, 123 Restricted Stock Units (RSUs) vested and were settled into 123 shares of CACI common stock, leaving her with 2,110 directly held shares and 369 RSUs still outstanding from a 492-unit grant made on October 16, 2025. On January 15, 2026, she received an additional 44 shares of common stock in connection with her annual retainer as Chair of the Board, bringing her direct holdings to 2,154 shares.
CACI International Inc. director Debora A. Plunkett reported the vesting of restricted stock units and corresponding issuance of common shares. On January 14, 2026, 84 Restricted Stock Units converted at an exercise price of $0.0000 per unit into 84 shares of CACI common stock, reported as a transaction with code "M." Following this transaction, she directly held 2,648 shares of CACI common stock and 254 Restricted Stock Units.
The footnote explains that on October 17, 2025, she was granted 338 Restricted Stock Units, scheduled to vest in four installments: 84 shares on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026.
CACI International director Ryan D. McCarthy reported the vesting and settlement of restricted stock units into common stock. On January 14, 2026, 84 Restricted Stock Units (RSUs) converted into 84 shares of CACI common stock at a reported price of $0.00 per share, reflecting a routine equity award vesting.
These RSUs were part of a 338-unit grant awarded on October 17, 2025, scheduled to vest in four tranches: 84 shares on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. After this transaction, McCarthy directly beneficially owned 2,153 shares of CACI common stock and 254 RSUs, all reported as directly held.
CACI International Inc. director reports stock sale
A director of CACI International Inc. (CACI), William L. Jews, reported selling 3,000 shares of CACI common stock on 12/10/2025. The sale was reported at a price of $585.82 per share. After this transaction, he beneficially owns 3,384 CACI common shares in direct ownership. The filing is a standard Form 4 insider transaction report and does not include any derivative securities activity.
CACI International (CACI) Chief Financial Officer Jeffrey D. MacLauchlan reported equity award vesting and related tax withholdings on 11/01/2025. He acquired 1,101 shares upon vesting of restricted stock units and 5,072 shares upon vesting of performance RSUs (both shown with code M). To cover taxes, the issuer withheld 541 shares and 2,488 shares at $562.25 per share (code F). Following these transactions, his directly held stake was 7,475 shares.
Footnotes state the RSUs were granted on November 1, 2022 and vest one-third per year over three years, while the PRSUs vested on the third anniversary based on a three‑year performance measure.